Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    ALX Oncology Inc.

    NASDAQ: ALXO · Real-Time Price · USD
    0.97
    0.33 (50.55%)
    At close: Aug 18, 2025, 3:59 PM

    ALX Oncology Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 872K 836K 1.47M 736K
    Gross Profit
    		 -872K -836K -1.47M -736K
    Operating Income
    		 -142.47M -170.28M -127.44M -83.56M
    Interest Income
    		 9.37M 10.65M 4.04M 91.00
    Pretax Income
    		 -134.85M -160.81M -123.42M -83.48M
    Net Income
    		 -134.85M -160.81M -123.48M -83.46M
    Selling & General & Admin
    		 26.09M 28.48M 29.04M 23.39M
    Research & Development
    		 116.37M 141.79M 98.4M 60.17M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 142.47M 170.28M 127.44M 83.56M
    Interest Expense
    		 1.73M 1.56M 238K 13K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 142.47M 170.28M 127.44M 83.56M
    Income Tax Expense
    		 n/a n/a 64K -21K
    Shares Outstanding (Basic)
    		 52.17M 42.99M 40.7M 40.31M
    Shares Outstanding (Diluted)
    		 52.17M 42.99M 40.7M 40.31M
    EPS (Basic)
    		 -2.58 -3.74 -3.03 -2.07
    EPS (Diluted)
    		 -2.58 -3.74 -3.03 -2.07
    EBITDA
    		 -132.25M -158.4M -121.95M -83.47M
    EBIT
    		 -133.12M -159.24M -123.42M -83.47M
    Depreciation & Amortization
    		 872K 836K 1.47M 51K

    Add to Watchlist